FabRx shortlisted as Finalists for the Most Valuable Breakthrough/Discovery

August 17, 2020 | Featured

We are thrilled to announce that FabRx and our new pharmaceutical 3D printer M3DIMAKER™ have been shortlisted for the ‘Most Valuable Breakthrough/Discovery’ category at the Reuters Events: Pharma Awards Europe. The awards are the biggest industry and patient value showcase in the world, with over 70 of the industry’s exclusive case studies exhibiting their work, narrowed down from hundreds of entrants.

With over 2,000 attendees present, winners will be revealed at the Virtual Exhibition & Showcase over three days, 19 – 21st October. 

The event is open to everyone so tell your colleagues and friends and register for free HERE! #REPAawards @rep_awards

Back to News

Copyright © 2021 FabRx Ltd